Publications by authors named "Mingning Ding"

Claim this Profile
T
Tao-Hong-Si-Wu-Tang improves thioacetamide-induced liver fibrosis by reversing ACSL4-mediated lipid accumulation and promoting mitophagy.
Jianzhi Wu, Liping Gong, Yufei Li, Jiaorong Qu, Yang Yang, Mingning Ding

J Ethnopharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead.
Runping Liu, Yajing Li, Qi Zheng, Mingning Ding, Huiping Zhou

Acta Pharm Sin B· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
extracts prevent liver fibrosis via targeting CTCF-c-MYC-H19 pathway.
Yajing Li, Fanghong Li, Mingning Ding, Zhi Ma, Shuo Li

Chin Herb Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurantio-obtusin ameliorates obesity by activating PPARα-dependent mitochondrial thermogenesis in brown adipose tissues.
Yi-Jie Li, Rui-Yu Wu, Run-Ping Liu, Kai-Yi Wu, Ming-Ning Ding

Acta Pharmacol Sin· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN.
Yajing Li, Zhi Ma, Mingning Ding, Kexin Jia, Bing Xu

Chin J Nat Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
improves non-alcoholic fatty liver disease through autophagy-related pathway.
Mingning Ding, Fei Zhou, Yijie Li, Chuanyang Liu, Yiqing Gu

Chin Herb Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.
Jia Liu, Mingning Ding, Jinzhao Bai, Ranyi Luo, Runping Liu

Imeta· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment.
Zhi Ma, Xiaoyong Xue, Jinzhao Bai, Yajie Cai, Xuejing Jin, Mingning Ding

Biomed Pharmacother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetramethylpyrazine prevents liver fibrotic injury in mice by targeting hepatocyte-derived and mitochondrial DNA-enriched extracellular vesicles.
Ya-Jing Li, Run-Ping Liu, Ming-Ning Ding, Qi Zheng, Jian-Zhi Wu

Acta Pharmacol Sin· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway.
Yiqing Gu, Shuni Duan, Mingning Ding, Qi Zheng, Guifang Fan

Phytomedicine· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurantio-Obtusin Attenuates Non-Alcoholic Fatty Liver Disease Through AMPK-Mediated Autophagy and Fatty Acid Oxidation Pathways.
Fei Zhou, Mingning Ding, Yiqing Gu, Guifang Fan, Chuanyang Liu

Front Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Si-Wu-Tang ameliorates fibrotic liver injury via modulating intestinal microbiota and bile acid homeostasis.
Xiaoyong Xue, Jianzhi Wu, Mingning Ding, Feng Gao, Fei Zhou

Chin Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis